Latest News articles in ICU
Xencor Appoints Barbara J. Klencke, M.D., to Board of Directors
Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases announced the appointment of Barbara J. Klencke, M.D., to its board of directors. Dr. Klencke has more than 20 years of bio
Read moreJeanette Hedén Carlsson Resigns as Executive Vice President Brand & Communication at Getinge
Getinge announces that Jeanette Hedén Carlsson has decided to resign after 6 years as Executive Vice President, Brand & Communication, and member of the Executive Team. The process to recruit a successor will start immediately. ”Jeanette has successfully built and developed effecti
Read more